X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/03/2875216/0/en/PharmAla-Launches-Prescriber-s-Portal-for-Medical-Professionals-Focused-on-MDMA-Therapy.html
https://www.globenewswire.com/news-release/2024/04/19/2866151/0/en/PharmAla-Closes-Private-Placement-and-Concurrent-Debt-Settlement.html
https://www.globenewswire.com/news-release/2024/04/10/2861135/0/en/PharmAla-Announces-Private-Placement-and-Concurrent-Debt-Settlement.html
https://www.globenewswire.com/news-release/2024/04/05/2858524/0/en/Cortexa-Commences-Manufacturing-GMP-LaNeo-MDMA-in-Australia.html
https://www.globenewswire.com/news-release/2024/03/27/2853085/0/en/Patent-Allowance-Granted-for-ALA-002-Composition-by-US-Patent-and-Trademark-Office.html
https://www.globenewswire.com/news-release/2024/03/26/2852377/0/en/PharmAla-Biotech-Signs-Sale-Agreement-with-Numinus.html
https://www.globenewswire.com/news-release/2024/03/20/2849490/0/en/Patent-Allowance-Granted-for-P-1-Molecule-by-US-Patent-and-Trademark-Office.html
https://www.globenewswire.com/news-release/2024/03/18/2847819/0/en/Cortexa-Leads-the-World-in-First-Supply-of-Psilocybin-Under-the-TGA-s-Authorized-Prescriber-Scheme.html
https://www.globenewswire.com/news-release/2024/03/18/2847819/0/en/Cortexa-Leads-the-World-in-First-Supply-of-Psilocybin-Under-the-TGA-s-Authorized-Prescriber-Scheme.html
https://www.globenewswire.com/news-release/2024/03/08/2843326/0/en/PharmAla-Announces-Voting-Results-of-Annual-General-and-Special-Meeting-of-Shareholders-and-Provides-Corporate-Update.html
Market Place
Share 
